Skip to content
Screener

Cytosorbents CTSO Q4 2025 Annual earnings

Reported March 25, 2026 · After market close

Revenue$9.2MMiss by $546.0K
EPS-$0.09Miss by $0.04
Revenue estimate$9.8M
EPS estimate-$0.05

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$9.9M
EPS estimate-$0.05

FAQ

When did Cytosorbents report Q4 2025 earnings?
Cytosorbents (CTSO) reported Q4 2025 earnings on March 25, 2026 after market close.
What were Cytosorbents's Q4 2025 revenue and EPS?
Cytosorbents reported revenue of $9.2M and eps of $-0.09 for Q4 2025.
Did Cytosorbents beat estimates in Q4 2025?
Revenue missed the consensus estimate of $9.8M by $546.0K. EPS missed the consensus estimate of $-0.05 by $0.04.
How did Cytosorbents's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 41.6% from $6.5M a year earlier and eps declined 200.0% from $-0.03.
Where can I find Cytosorbents's Q4 2025 SEC filings?
You can read the 8-K earnings release (0000929638-26-001150) and the 10-K periodic report (0001104659-26-036451) directly on SEC EDGAR. The filing index links above go to sec.gov.